Formoterol is a long-acting beta-agonist (LABA) bronchodilator, which provides long-term asthma management rather than quick symptom relief. However, the idea behind SMART therapy is that ...

The FDA has requested five large clinical trials to evaluate fixed-dose ICS–LABA products with the primary outcome of life-threatening asthma exacerbation or death. The results will not be ...

The inhaler is not reusable. LABA as monotherapy (without ICS) for asthma can increase risk of asthma-related events. Do not initiate in rapidly deteriorating or potentially life-threatening ...